
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
Mease, Philip J, Smolen, Josef S, Behrens, Frank, Nash, Peter, Liu Leage, Soyi, Li, Lingnan, Tahir, Hasan, Gooderham, Melinda, Krishnan, Eswar, Liu-Seifert, Hong, Emery, Paul, Pillai, Sreekumar G, HelVolume:
79
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2019-215386
Date:
January, 2020
Fichier:
PDF, 917 KB
2020